Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q2 2023 · 10-Q
Revenue$60.99M$60.99M+71.2% vs Q2 2022 Net Income-$12.23M-$12.23MN/M vs Q2 2022 EPS Diluted-$0.17-$0.17N/M vs Q2 2022 Gross Profit$10,369,000+102.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flowderived-$8,197,000N/M Free Cash Flowderived-$8,941,000N/M Margins · derivedGross margin17.0%+2.7 pt vs Q2 2022
Operating margin-20.0%+7.3 pt vs Q2 2022
Net margin-20.1%−43.7 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 9, 2023 · 40 d after period end